Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 29
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Absence of Pathogenic Mutations and Strong Association With HLA-DRB1∗11:01 in Statin-Naïve Early-Onset Anti-HMGCR Necrotizing Myopathy

  • Llansó, Laura|||0000-0003-4950-7657
  • Segarra Casas, Alba|||0000-0001-5185-5031
  • Domínguez-González, Cristina|||0000-0001-5151-988X
  • Malfatti, Edoardo|||0000-0001-7871-8600
  • Kapetanovic, S.
  • Rodriguez Santiago, Benjamin|||0000-0003-1167-3852
  • Calle Martín, Óscar de la|||0000-0001-9717-053X
  • Blanco, Ricardo|||0000-0003-2344-2285
  • Dobrescu, A.
  • Nascimiento Osorio, Andrés
  • Paipa, Andrés
  • Hernandez-Lain, A.
  • Jou, C.
  • Mariscal, Anaís|||0000-0003-1013-4793
  • González Mera, Laura
  • Arteche, A.
  • Lleixà, Cinta|||0000-0002-9971-0584
  • Caballero-Ávila, Marta|||0000-0001-9850-8504
  • Carbayo Viejo, Álvaro|||0000-0001-9282-8603
  • Vesperinas-Castro, Ana|||0000-0003-1919-9382
  • Querol, Luis|||0000-0002-4289-8264
  • Gallardo, Eduard|||0000-0002-3942-3436
  • Olivé i Plana, Montserrat|||0000-0001-5727-0165
Background and Objectives Immune-mediated necrotizing myopathy (IMNM) caused by antibodies against 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) is an inflammatory myopathy that has been epidemiologically correlated with previous statin exposure. We characterized in detail a series of 11 young statin-naïve patients experiencing a chronic disease course mimicking a limb-girdle muscular dystrophy. With the hypothesis that HMGCR upregulation may increase immunogenicity and trigger the production of autoantibodies, our aim was to expand pathophysiologic knowledge of this distinct phenotype. MethodsClinical and epidemiologic data, autoantibody titers, creatine kinase (CK) levels, response to treatment, muscle imaging, and muscle biopsies were assessed. HMGCR expression in patients' muscle was assessed by incubating sections of affected patients with purified anti-HMGCR+ serum. Whole-exome sequencing (WES) with a special focus on cholesterol biosynthesis-related genes and high-resolution human leukocyte antigen (HLA) typing were performed. Results Patients, aged 3-25 years and mostly female (90.9%), presented with subacute proximal weakness progressing over many years and high CK levels (.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A Homozygous ATP2A2 Variant Alters Sarcoendoplasmic Reticulum Ca2+-ATPase 2 Function in Skeletal Muscle and Causes a Novel Vacuolar Myopathy

  • Llansó, Laura|||0000-0003-4950-7657
  • Ravenscroft, Gianina|||0000-0003-3634-211X
  • Aceituno, Cristina
  • Gutiérrez, Antonio|||0000-0001-9062-077X
  • Parmar, Jevin|||0000-0003-1864-8094
  • Gallano, Pia|||0000-0001-8104-2197
  • Caballero-Ávila, Marta|||0000-0001-9850-8504
  • Carbayo Viejo, Álvaro|||0000-0001-9282-8603
  • Vesperinas-Castro, Ana|||0000-0003-1919-9382
  • Collet Vidiella, Roger|||0000-0003-1668-1018
  • Blanco, Rosa
  • Laing, Nigel|||0000-0001-5111-3732
  • Madsen, Leif Hove|||0000-0001-5493-3998
  • Gallardo, Eduard|||0000-0002-3942-3436
  • Olivé i Plana, Montserrat|||0000-0001-5727-0165
Aims: Sarcoendoplasmic reticulum Ca-ATPase 2 (SERCA2), encoded by ATP2A2, is a key protein involved in intracellular Ca homeostasis. The SERCA2a isoform is predominantly expressed in cardiomyocytes and type I myofibres. Variants in this gene are related to Darier disease, an autosomal dominant dermatologic disorder, but have never been linked to myopathy. We describe four patients suffering from a novel myopathy caused by a homozygous missense variant in ATP2A2. Methods: We studied a family with four individuals suffering from an adult-onset skeletal myopathy. We evaluated the clinicopathological phenotype, muscle imaging, and genetic workup including whole genome sequencing and segregation analysis. SERCA2 expression in skeletal muscle was assessed. Functional studies to evaluate Ca handling in patient myotubes in response to electrical stimulation or caffeine exposure were performed. Results: Four sisters developed slowly progressive proximal weakness in adulthood. Biopsy findings showed small vacuoles restricted to type I myofibres. Ultrastructural analysis showed sarcotubular dilation and autophagic vacuoles. Genome sequencing revealed a homozygous variant in ATP2A2 (c.1117G.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Minimizing Human Labeling in Training Deep Models for Pedestrian Intention Prediction

  • Riaz, Muhammad Naveed|||0000-0002-0250-5913
  • Wielgosz, Maciej|||0000-0002-4401-2957
  • López Peña, Antonio M.|||0000-0002-6979-5783
Accurately predicting whether pedestrians will cross in front of an autonomous vehicle is essential for ensuring safe and comfortable maneuvers. However, developing models for this task remains challenging due to the limited availability of diverse datasets containing both crossing (C) and non-crossing (NC) scenarios. Therefore, we propose a procedure that leverages synthetic videos with C/NC labels and an untrained model whose architecture is designed for C/NC prediction to automatically produce C/NC labels for a set of real-world videos. Thus, this procedure performs a synth-to-real unsupervised domain adaptation for C/NC prediction, so we term it S2R-UDA-CP. To assess the effectiveness of S2R-UDA-CP in self-labeling, we utilize two state-of-the-art models, PedGNN and ST-CrossingPose, and we rely on the publicly-available PedSynth dataset, which consists of synthetic videos with C/NC labels. Notably, once the real-world videos are self-labeled, they can be used to train models different from those used in S2R-UDA-CP. These models are designed to operate onboard a vehicle, whereas S2R-UDA-CP is an offline procedure. To evaluate the quality of the C/NC labels generated by S2R-UDA-CP, we also employ PedGraph+ (another literature referent) as it is not used in S2R-UDA-CP. Overall, the results show that training models to predict C/NC using videos labeled by S2R-UDA-CP achieves performance even better than models trained on human-labeled data. Our study also highlights different discrepancies between automatic and human labeling. To the best of our knowledge, this is the first study to evaluate synth-to-real self-labeling for C/NC prediction.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group

  • Oñate, Guadalupe|||0000-0003-2180-2371
  • Garrido Diaz, Ana|||0000-0002-5297-8946
  • Arnan, Montserrat
  • Pomares, Helena
  • Alonso, Ester
  • Tormo, Mar|||0000-0001-9622-1649
  • Díaz-Beyá, Marina|||0000-0001-9624-2597
  • Vives Polo, Susana|||0000-0003-2217-5285
  • Zamora, Lurdes|||0000-0003-1713-7110
  • Sampol, Antonia|||0000-0001-7465-6203
  • Coll, Rosa|||0000-0003-0560-1254
  • Salamero, Olga|||0000-0003-3237-0025
  • Cervera, Marta
  • Garcia-Guiñon, Antonio|||0000-0003-0006-4162
  • Vall-Llovera, Ferran|||0000-0002-0718-5955
  • Garcia-Avila, Sara|||0000-0002-9293-2029
  • Bargay, Joan|||0000-0002-6739-3916
  • Ortin, Xavier
  • Iranzo, Eva
  • Guijarro, Francesca|||0000-0001-6376-0929
  • Pratcorona, Marta|||0000-0001-6375-596X
  • Nomdedeu Guinot, Jose Francisco|||0000-0003-3399-346X
  • Esteve Reyner, Jordi|||0000-0002-8056-648X
  • Sierra, Jorge|||0000-0002-7966-0356
Given the heterogeneity of acute myeloid leukemia patients, it is necessary to identify patients considered fit for intensive therapy but who will perform poorly, and in whom alternative approaches deserve investigation. We analyzed 1034 fit adults ≤70 years intensively treated between 2012 and 2022 in the CETLAM group. Young adults ( ≤ 60 years) presented higher remission rates and improved survival than older adults above that age (CR 79% vs. 73%; p = 0.03 and 4-yr OS 53% vs. 33%; p < 0.001). Remission and survival outcomes varied among different genetic subsets. An especially adverse genetic group included complex, monosomal karyotype, TP53 alterations (deleted/mutated), and MECOMr. Transplant feasibility in this very adverse risk group was low, and OS and EFS at 4 years were 14% and 12%, in contrast to 70% and 57% in the favorable group and 38% and 32% in all other patients. We integrated clinical and genetic data into the Intensive Chemotherapy Score for AML (ICSA) with 6-risk categories with significantly different remission rates and OS, validated in another cohort of 581 AML patients from a previous CETLAM protocol. In summary, we identified groups of fit patients that benefit differently from an intensive approach which may be helpful in future treatment decisions.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Repeat Expansions in PLIN4 Cause Autosomal Dominant Vacuolar Myopathy With Sarcolemmal Features

  • Llansó, Laura|||0000-0003-4950-7657
  • Stevanovski, Igor
  • Morís, Germán|||0000-0001-7608-2194
  • Collet Vidiella, Roger|||0000-0003-1668-1018
  • Segarra Casas, Alba|||0000-0001-5185-5031
  • González Quereda, Lidia|||0000-0003-0715-6414
  • Rodriguez Santiago, Benjamin|||0000-0003-1167-3852
  • Gallano, Pia|||0000-0001-8104-2197
  • Alvarez, Rodrigo
  • Vesperinas-Castro, Ana|||0000-0003-1919-9382
  • Blanco, Rosa
  • San-Millán, Beatriz
  • Navarro, Carmen|||0000-0003-4445-8585
  • Illa, Isabel|||0000-0002-2186-2684
  • Ravenscroft, Gianina|||0000-0003-3634-211X
  • W. Deveson, Ira
  • Gallardo, Eduard|||0000-0002-3942-3436
  • Olivé i Plana, Montserrat|||0000-0001-5727-0165
Objective: We aim to describe and characterize two unrelated Spanish families suffering from an autosomal dominant autophagic vacuolar myopathy caused by repeat expansions in PLIN4. Methods: We evaluated the clinical phenotype and muscle imaging, and performed a genetic workup that included exome sequencing, muscle RNAseq, and long-read genome sequencing. Muscle pathology was assessed by means of histochemistry, electron microscopy, PLIN4, p62, LC3, and NBR1 immunofluorescence and/or western blotting. Detailed characterization of autophagic vacuoles was performed. Results: Patients presented around the age of 30 with mild proximal weakness followed by prominent distal weakness in lower legs, eventually spreading to other muscle groups. Muscle biopsies showed unique pathological features characterized by numerous rimmed vacuoles that displayed sarcolemmal features and were located beneath the sarcolemma and within the cytoplasm. Ultrastructural studies showed autophagic vacuoles, replications, and loops of the basal lamina and tubulofilamentous sarcoplasmic inclusions. p62 and NBR1 co-localized with PLIN4 at the sarcolemma and vacuoles. LC3 immunoreactivity and other lysosomal markers were increased at the vacuoles. Targeted long-read sequencing of PLIN4 in affected individuals revealed a single expanded allele of 39 × 99 bp repeats in family 1 and of 37 × 99 bp repeats in family 2. Interpretation: We characterize two new families suffering from an autosomal dominant myopathy carrying repeat expansions in PLIN4. Subsarcolemmal p62 expression is a powerful although nonspecific marker of this disease. No correlation between the size of the expansion and clinical severity can be clearly established. PLIN4 expansions should be considered in the diagnosis of autosomal dominant vacuolar myopathies, especially when sarcolemmal features are present.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Novel DES mutation presenting with isolated restrictive respiratory failure. Expanding the clinical spectrum, Una nueva mutación en DES se manifiesta como una insuficiencia respiratoria aislada. Expandiendo el espectro clínico

  • Alonso Pérez, Jorge|||0000-0001-8866-5186
  • Barrachina Esteve, Oriol|||0000-0002-8519-0784
  • González Quereda, Lidia|||0000-0003-0715-6414
  • Viguera-Martinez, Maria Luisa|||0000-0003-1072-9922
  • Luján, Manel|||0000-0001-9033-7712
  • Guitart Feliubadalo, Maria
  • Miguel Martínez, J.
  • Carbayo Viejo, Álvaro|||0000-0001-9282-8603
  • Gallano, Pia|||0000-0001-8104-2197
  • Diaz-Manera, Jordi|||0000-0003-2941-7988
  • Olivé, M.
  • Rojas-Garcia, Ricard|||0000-0003-1411-5573
Background: Desminopathies are a clinically heterogeneous group of myopathies, with common histological findings in muscle biopsy. Clinically, they usually present with distal and/or proximal muscle weakness often associated with cardiomyopathy. We present 8 patients from 3 unrelated families manifesting isolated respiratory insufficiency without skeletal muscle weakness or heart disease, because of a mutation in the DES gene. Methods: Clinical and demographic data were acquired from medical records. Muscle MRI studies were performed in 6 patients. A muscle biopsy study was performed in the index case from each family. Results: Isolated restrictive respiratory dysfunction was observed in all symptomatic patients, with 2 requiring non-invasive ventilation. Three patients were asymptomatic at the time of the study. None of the patients presented skeletal muscle weakness or heart disease, even after 20 years of disease progression. Muscle MRI showed a common pattern with predominant involvement of the semitendinosus muscle. Muscle biopsy showed patches of cytoplasmic inclusions corresponding to desmin aggregates. The genetic study showed heterozygous presence of the p.Arg415Trp mutation in the DES gene in all patients. Conclusions: We present 5 patients carrying a p.Arg415Trp mutation in the DES gene, manifesting as isolated restrictive respiratory insufficiency without associated skeletal muscle weakness or heart disease. These cases represent a new phenotype associated with DES mutations, thus suggesting that desminopathy should be considered in the diagnostic workup of patients presenting isolated respiratory failure., Antecedentes: Las desminopatías son un grupo de miopatías clínicamente heterogéneas, que comparten hallazgos histológicos comunes en la biopsia muscular. Clínicamente, suelen presentarse con una debilidad muscular distal y/o proximal que a menudo se asocia con una miocardiopatía. Presentamos ocho pacientes de tres familias no emparentadas que se manifiestan como una insuficiencia respiratoria aislada sin debilidad musculoesquelética ni cardiopatía asociada como consecuencia de una mutación en el gen DES. Métodos: Los datos clínicos y demográficos se obtuvieron de las historias clínicas. Se realizó estudio de resonancia magnética muscular en seis pacientes. En los casos índices de cada familia se realizó una biopsia muscular. Resultados: Se observó una disfunción respiratoria restrictiva aislada en todos los pacientes sintomáticos, requiriendo VNI en dos de ellos. Tres pacientes estaban asintomáticos en el momento del estudio. Ninguno de los pacientes presentaron debilidad musculoesquelética o cardiopatía, incluso después de 20 anos ˜ de evolución de la enfermedad. La RM muscular mostró un patrón común con afectación predominante del músculo semitendinoso. La biopsia muscular mostró parches de inclusiones citoplasmáticas correspondientes a agregados de desmina. El estudio genético mostró la misma mutación p.Arg415Trp en heterocigocis en el gen DES en todos los pacientes estudiados. Conclusiones: Presentamos cinco pacientes portadores de la mutación p.Arg415Trp en el gen DES que se manifiesta únicamente como una insuficiencia respiratoria restrictiva aislada sin debilidad musculoesquelética asociada ni cardiopatía. Estos casos representan un nuevo fenotipo asociado con mutaciones DES, lo que sugiere que las desminopatías deben ser consideradas en el proceso diagnóstico de los pacientes con una insuficiencia respiratoria aislada.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Precision targeting of CXCR4+ leukemia cells by a humanized MMAE-nanoconjugate in an AML mouse model

  • Garcia León, Annabel|||0000-0003-3007-9306
  • Mendoza, Julian Ignacio|||0000-0002-1975-3606
  • Rueda, Ariana|||0000-0001-7588-9279
  • Alba Castellón, Lorena|||0000-0003-3449-7820
  • Nomdedeu Guinot, Jose Francisco|||0000-0003-3399-346X
  • Gallardo, Alberto|||0000-0002-2514-2027
  • Sierra, Jorge|||0000-0002-7966-0356
  • Garrido Diaz, Ana|||0000-0002-5297-8946
  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Mangues, Ramon|||0000-0003-2661-9525
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
Acute myeloid leukemia (AML) presents major clinical challenges due to chemoresistance and high relapse rates, primarily driven by therapy-resistant leukemic stem cells (LSCs) within the bone marrow. To address this issue, we developed T22-HSNBT-H6-MMAE, a novel humanized nanoconjugate designed to target CXCR4 cells while delivering the cytotoxic payload monomethyl auristatin E (MMAE). CXCR4 signaling pathway plays a critical role in LSC survival by preserving stem-like properties and activating protective mechanisms that promote treatment resistance. Moreover, CXCR4 is overexpressed in approximately 50 % of AML patients and is associated with poor prognosis and high relapse rates. We evaluated the therapeutic potential of T22-HSNBT-H6-MMAE using in vitro assays with AML cell lines and primary patient samples, as well as in vivo studies in a disseminated AML mouse model. Our results demonstrated that T22-HSNBT-H6-MMAE exerts a CXCR4-dependent cytotoxic effect through mitotic catastrophe and apoptosis induction in CXCR4 AML cell lines. In vivo evaluation in a disseminated CXCR4 AML mouse model showed potent antineoplastic activity, with complete suppression of leukemic dissemination and significantly prolonged survival, all without systemic toxicity. Notably, the nanoconjugate remained effective even in models with extensive bone marrow involvement and exhibited activity against diverse patient-derived CXCR4 AML blasts, while sparing healthy donor bone marrow and peripheral blood mononuclear cells (PBMCs) from significant toxicity. Collectively, these findings highlight T22-HSNBT-H6-MMAE as a promising therapeutic candidate for a broad range of AML patients, offering selective antineoplastic activity against CXCR4 leukemic cells.
Repisalud
Publicación Artículo científico (JournalArticle)

Ocoxin Modulates Cancer Stem Cells and M2 Macrophage Polarization in Glioblastoma

  • Hernandez-SanMiguel, Esther
  • Gargini, Ricardo
  • Cejalvo, Teresa
  • Segura-Collar, Berta
  • Nuñez-Hervada, Paula
  • Hortigüela, Rafael
  • Sepúlveda-Sánchez, Juan Manuel
  • Hernández-Laín, Aurelio
  • Pérez-Núñez, Ángel
  • Sanz, Eduardo
  • Sánchez-Gómez, Pilar
Glioblastoma (GBM) is the most common and devastating primary brain tumor. The presence of cancer stem cells (CSCs) has been linked to their therapy resistance. Molecular and cellular components of the tumor microenvironment also play a fundamental role in the aggressiveness of these tumors. In particular, high levels of hypoxia and reactive oxygen species participate in several aspects of GBM biology. Moreover, GBM contains a large number of macrophages, which normally behave as immunosuppressive tumor-supportive cells. In fact, the presence of both, hypoxia and M2-like macrophages, correlates with malignancy and poor prognosis in gliomas. Antioxidant agents, as nutritional supplements, might have antitumor activity. Ocoxin® oral solution (OOS), in particular, has anti-inflammatory and antioxidant properties, as well as antitumor properties in several neoplasia, without known side effects. Here, we describe how OOS affects stem cell properties in certain GBMs, slowing down their tumor growth. In parallel, OOS has a direct effect on macrophage polarization in vitro and in vivo, inhibiting the protumoral features of M2 macrophages. Therefore, OOS could be a feasible candidate to be used in combination therapies during GBM treatment because it can target the highly resilient CSCs as well as their supportive immune microenvironment, without adding toxicity to conventional treatments.
Repisalud
Publicación Artículo científico (JournalArticle)

Immune Profiling of Gliomas Reveals a Connection with IDH1/2 Mutations, Tau Function and the Vascular Phenotype

  • Cejalvo, Teresa
  • Gargini, Ricardo
  • Segura-Collar, Berta
  • Mata-Martínez, Pablo
  • Herranz, Beatriz
  • Cantero, Diana
  • Ruano, Yolanda
  • García-Pérez, Daniel
  • Pérez-Núñez, Ángel
  • Ramos, Ana
  • Hernández-Laín, Aurelio
  • Martín-Soberón, María Cruz
  • Sánchez-Gómez, Pilar
  • Sepúlveda-Sánchez, Juan Manuel
Background: Gliomas remain refractory to all attempted treatments, including those using immune checkpoint inhibitors. The characterization of the tumor (immune) microenvironment has been recognized as an important challenge to explain this lack of response and to improve the therapy of glial tumors. Methods: We designed a prospective analysis of the immune cells of gliomas by flow cytometry. Tumors with or without isocitrate dehydrogenase 1/2 (IDH1/2) mutations were included in the study. The genetic profile and the presence of different molecular and cellular features of the gliomas were analyzed in parallel. The findings were validated in syngeneic mouse models. Results: We observed that few immune cells infiltrate mutant IDH1/2 gliomas whereas the immune content of IDH1/2 wild-type tumors was more heterogeneous. Some of them contained an important immune infiltrate, particularly enriched in myeloid cells with immunosuppressive features, but others were more similar to mutant IDH1/2 gliomas, with few immune cells and a less immunosuppressive profile. Notably, we observed a direct correlation between the percentage of leukocytes and the presence of vascular alterations, which were associated with a reduced expression of Tau, a microtubule-binding protein that controls the formation of tumor vessels in gliomas. Furthermore, overexpression of Tau was able to reduce the immune content in orthotopic allografts of GL261 cells, delaying tumor growth. Conclusions: We have confirmed the reduced infiltration of immune cells in IDH1/2 mutant gliomas. By contrast, in IDH1/2 wild-type gliomas, we have found a direct correlation between the presence of vascular alterations and the entrance of leukocytes into the tumors. Interestingly, high levels of Tau inversely correlated with the vascular and the immune content of gliomas. Altogether, our results could be exploited for the design of more successful clinical trials with immunomodulatory molecules.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Asignación Dinámica de Recursos en Sistemas de Control de Tiempo Real, Dynamic resource allocation in real-time control systems

  • Martí, Pau
  • Lin, Caixue
  • Brandt, Scott A.
  • Velasco, Manel
  • Ayza, Jordi
  • Fuertes, Josep M.
[EN] Most traditional resource management techniques for real-time systems with multiple control loops are based on "open-loop" strategies that statically allocate a constant CPU share to each control task, independent of the plant dynamics of each control loop. This provides average control performance with minimal overhead but in general fails to provide the best performance possible within the available resources. We show that by using dynamic resource allocation for control tasks, overall control performance can be significantly improved. We present an optimal resource allocation policy that maximizes control performance within the available resources. We provide experimental results on a real-time system that show the benefits of the proposed policies and corroborate the presented theoretical results., [ES] Las técnicas tradicionales de tiempo real realizan la asignación de recursos a las tareas de control basándose en estrategias en "lazo abierto" que asignan (a priori) una porción de procesador a cada tarea. Esta asignación es estática desde un punto de vista de recursos, es decir, a lo largo de toda la vida de la aplicación se mantiene constante independientemente de la dinámica que cada lazo de control tenga en tiempo de ejecución. El uso de asignaciones estáticas proporciona un rendimiento de control medio, con mínimo coste computacional, pero no consiguen proporcionar el mejor rendimiento que puede obtenerse con los recursos de cómputo disponibles. En este trabajo mostramos cómo, asignando de forma dinámica los recursos a las tareas de control, el rendimiento proporcionado por el conjunto de la aplicación mejora significativamente. Además presentamos la política de asignación de recursos óptima respecto al rendimiento proporcionado por las tareas de control. Los resultados experimentales realizados sobre una plataforma de tiempo real muestran los beneficios de la políticas propuestas y avalan los resultados teóricos presentados., Este trabajo ha sido financiado parcialmente por Intel Corporation, por Departament d'Universitats, Recerca i Societat de la Informació de la Generalitat de Catalunya, y por el proyecto CICYT ref. DPI2002-01621.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Plastidial Glyceraldehyde-3-Phosphate Dehydrogenase Deficiency Leads to Altered Root Development and Affects the Sugar and Amino Acid Balance in Arabidopsis

  • Muñoz Bertomeu, Jesús
  • Cascales Miñana, Borja
  • Baroja-Fernández, Edurne
  • Pozueta Romero, Javier
  • Kuhn, Josef M.
  • Segura Garcia del Rio, Juan
  • Ros Palau, Roc
  • Mulet, José Miguel|||0000-0002-9087-3838
[EN] Glycolysis is a central metabolic pathway that, in plants, occurs in both the cytosol and the plastids. The glycolytic glyceraldehyde-3-phosphate dehydrogenase (GAPDH) catalyzes the conversion of glyceraldehyde-3-phosphate to 1,3-bisphosphoglycerate with concomitant reduction of NAD(+) to NADH. Both cytosolic (GAPCs) and plastidial (GAPCps) GAPDH activities have been described. However, the in vivo functions of the plastidial isoforms remain unresolved. In this work, we have identified two Arabidopsis (Arabidopsis thaliana) chloroplast/plastid-localized GAPDH isoforms (GAPCp1 and GAPCp2). gapcp double mutants display a drastic phenotype of arrested root development, dwarfism, and sterility. In spite of their low gene expression level as compared with other GAPDHs, GAPCp down-regulation leads to altered gene expression and to drastic changes in the sugar and amino acid balance of the plant. We demonstrate that GAPCps are important for the synthesis of serine in roots. Serine supplementation to the growth medium rescues root developmental arrest and restores normal levels of carbohydrates and sugar biosynthetic activities in gapcp double mutants. We provide evidence that the phosphorylated pathway of Ser biosynthesis plays an important role in supplying serine to roots. Overall, these studies provide insights into the in vivo functions of the GAPCps in plants. Our results emphasize the importance of the plastidial glycolytic pathway, and specifically of GAPCps, in plant primary metabolism., This work was supported by the European Union (Sixth Framework programme, grant no. MOIF-CT-2004-50927), by the Spanish Government (grant no. BFU2006-01621/BFI), by the Valencian Government (grant nos. PROMETEO/2009/075 and ACOMP/2009/328), by a Formacion de Profesorado Universitario research fellowship from the Spanish Government to B. C.-M., and by the National Institutes of Health and the National Science Foundation (grant nos. GM060396 and MCB0417118, respectively, to Julian Schroeder at University of California San Diego).
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Cognitive, community functioning and clinical correlates of the Clinical Assessment Interview for Negative Symptoms (CAINS) in psychotic disorders

  • Cuesta, Manuel J.
  • Sánchez Torres, Ana María
  • Lorente Omeñaca, Ruth
  • Moreno-Izco, Lucía
  • Peralta Martín, Víctor
  • SEGPEPs Group
Negative symptoms are a core dimension of schizophrenia and other psychoses that account for a large degree of the poor functional outcomes related to these disorders. Newer assessment scales for negative symptoms, such as the Clinical Assessment Interview for Negative Symptoms (CAINS), provide evidence for separate dimensions of motivational and pleasure (MAP) and expression (EXP) dimensions. This study was aimed at extending the analysis of the clinical, functional and cognitive correlates of CAINS dimensions in a sample of patients with psychotic disorders (n=98) and 50 healthy controls. A psychopathological evaluation was conducted by using the Comprehensive Assessment of Symptoms and History (CASH). To assess the extrapyramidal signs, the UKU scale was used. Community functioning was evaluated by means of real-world and functional attainment measures. Additionally, a full neuropsychological test battery was administered. Pearson correlation and hierarchical multiple linear regression analyses were performed to identify the infuencing and predictive factors associated with the CAINS dimensions. The MAP and EXP dimensions showed strong associations with the Scale for the Assessment of Negative Symptoms (SANS) items and were not signifcantly associated with extra-pyramidal or cognitive defcits. The MAP and EXP CAINS dimensions revealed good predictive validity for real-world functioning and functional attainment measures. These fndings suggest that the CAINS scale endorses good convergent validity for the assessment of negative symptoms and is very useful in the prediction of psychosocial functioning. In addition, the CAINS dimensions might provide advantages over old assessment scales on disentangling the complex associations between negative symptoms and cognitive impairment., This work was supported by the Government of Navarra (grants 17/31, 18/41, 87/2014) and the Carlos III Health Institute (FEDER Funds) from the Spanish Ministry of Economy and Competitivity (14/01621 and 16/02148).
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Influence of social cognition as a mediator between cognitive reserve and psychosocial functioning in patients with first episode psychosis

  • González-Ortega, Itxaso
  • González Pinto, Ana
  • Alberich, Susana
  • Echeburúa, Enrique
  • Bernardo, Miguel
  • Cabrera, Bibiana
  • Amoretti, Silvia
  • Lobo, Antonio
  • Arango, Celso
  • Corripio, Iluminada
  • Vieta, Eduard
  • Serna, Elena de la
  • Rodríguez-Jiménez, Roberto
  • Segarra-Echevarría, Rafael
  • López-Ilundain, José M.
  • Sánchez Torres, Ana María
  • Cuesta, Manuel J.
  • PEPs Group
Background. Social cognition has been associated with functional outcome in patients with first episode psychosis (FEP). Social cognition has also been associated with neurocognition and cognitive reserve. Although cognitive reserve, neurocognitive functioning, social cognition, and functional outcome are related, the direction of their associations is not clear. Therefore, the main aim of this study was to analyze the influence of social cognition as a mediator between cognitive reserve and cognitive domains on functioning in FEP both at baseline and at 2 years. Methods The sample of the study was composed of 282 FEP patients followed up for 2 years. To analyze whether social cognition mediates the influence of cognitive reserve and cognitive domains on functioning, a path analysis was performed. The statistical significance of any mediation effects was evaluated by bootstrap analysis. Results. At baseline, as neither cognitive reserve nor the cognitive domains studied were related to functioning, the conditions for mediation were not satisfied. Nevertheless, at 2 years of follow-up, social cognition acted as a mediator between cognitive reserve and functioning. Likewise, social cognition was a mediator between verbal memory and functional outcome. The results of the bootstrap analysis confirmed these significant mediations (95% bootstrapped CI (—10.215 to —0.337) and (—4.731 to —0.605) respectively). Conclusions. Cognitive reserve and neurocognition are related to functioning, and social cognition mediates in this relationship., This work was supported by the Carlos III Institute of Health and European Fund for Regional Development (PI08/1213, PI11/ 01977, PI14/01900, PI08/01026, PI11/02831, PI14/01621, PI08/1161, PI16/ 00359, PI16/01164, PI18/00805), the Basque Foundation for Health Innovation and Research (BIOEF), the Secretaria d´Universitats I Recerca del Departament d´Economia I Coneixement (2017 SGR 1365), and R&D activities in Biomedicine, Madrid Regional Government and Structural Funds of the European Union (S2017/BMD-3740 (AGES-CM 2-CM)).
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Relapse of first-episode schizophrenia patients and neurocognitive impairment: the role of dopaminergic and anticholinergic burden

  • Cuesta, Manuel J.
  • Ballesteros, Alejandro
  • Sánchez Torres, Ana María
  • Amoretti, Silvia
  • López-Ilundain, José M.
  • Merchán-Naranjo, Jessica
  • González-Ortega, Itxaso
  • Salgado, Purificación
  • Rodríguez-Jiménez, Roberto
  • Roldán-Bejarano, Alexandra
  • Sarró, Salvador
  • Ibáñez, Ángela
  • Usall, Judith
  • Escartí, Maria José
  • Moreno-Izco, Lucía
  • Mezquida, Gisela
  • Parellada, Mara
  • González Pinto, Ana
  • Berrocoso, Esther
  • Bernardo, Miguel
  • 2EPs Group
Background: the prevention of relapse may be a key factor to diminish the cognitive impairment of first-episode schizophrenia (FES) patients. We aimed to ascertain the effects of relapse, and dopaminergic and anticholinergic treatment burdens on cognitive functioning in the follow-up. Methods: ninety-nine FES patients participated in this study. Cognitive assessments were performed at baseline and after 3 years of follow-up or, in those patients who relapsed, after >2 months of stabilization of the new acute psychotic episode. The primary outcomes were final cognitive dimensions. Results: repeated measures MANOVA analyses showed improvements in the whole sample on the end-point assessments in processing speed and social cognition. However, only impairment in social cognition showed a significant interaction with relapse by time in this sample. Relapse in FES patients was significantly associated with poor performance on end-point assessments of working memory, social cognition and global cognitive score. Anticholinergic burden, but not dopaminergic burden, was associated with verbal memory impairment. These significant associations resulted after controlling for baseline cognitive functioning, relapse and dopaminergic burden. Conclusions: the relationship between relapse and cognitive impairment in recovered FES patients seems to be particularly complex at the short-term follow-up of these patients. While relapse was associated with working memory, social cognition impairments and global cognitive score, anticholinergic burden might play an additional worsening effect on verbal memory. Thus, tailoring or changing antipsychotics and other drugs to reduce their anticholinergic burden may be a potential modifiable factor to diminish cognitive impairment at this stage of the illness., We would also like to thank the Carlos III Healthcare Institute, the Spanish Ministry of Science, Innovation and Universities, the European Regional Development Fund (ERDF/FEDER) (PI08/0208, PI11/00325, PI14/00612); CIBERSAM; CERCA Program; Catalan Government, the Secretariat of Universities and Research of the Department of Enterprise and Knowledge (2017SGR1355) and Institut de Neurociències, Universitat de Barcelona. This work was supported by the Carlos III Health Institute (FEDER Funds) from the Spanish Ministry of Economy and Competitivity (08/01026, 11/02831, 14/01621 and 19/1698), and the Government of Navarra (18/41).
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Individual trajectories of cognitive performance in first episode psychosis: a 2-year follow-up study

  • Sánchez Torres, Ana María
  • Moreno-Izco, Lucía
  • Lorente Omeñaca, Ruth
  • Cabrera, Bibiana
  • Lobo, Antonio
  • González Pinto, Ana
  • Merchán-Naranjo, Jessica
  • Corripio, Iluminada
  • Vieta, Eduard
  • Serna, Elena de la
  • Butjosa, Anna
  • Contreras, Fernando
  • Sarró, Salvador
  • Mezquida, Gisela
  • Ribeiro Fernández, María
  • Bernardo, Miguel
  • Cuesta, Manuel J.
  • PEPs Group
Individual changes over time in cognition in patients with psychotic disorders have been studied very little, especially in the case of frst episode psychosis (FEP). We aimed to establish whether change in individual trajectories in cognition over 2 years of a sample of 159 FEP patients was reliable and clinically signifcant, using the reliable change index (RCI) and clinically signifcant change (CSC) methods. We also studied a sample of 151 matched healthy controls. Patients and controls were assessed with a set of neuropsychological tests, as well as premorbid, clinical and functionality measures. We analysed the course of cognitive measures over time, using analysis of variance, and the individual trajectories in the cognitive measures with the regression-based RCI (RCISRB) and the CSC. The RCISRB showed that between 5.4 and 31.2% of the patients showed deterioration patterns, and between 0.6 and 8.8% showed improvement patterns in these tests over time. Patients showing better cognitive profles according to RCISRB (worsening in zero to two cognitive measures) showed better premorbid, clinical and functional profles than patients showing deterioration patterns in more than three tests. When combining RCISRB and CSC values, we found that less than 10% of patients showed improvement or deterioration patterns in executive function and attention measures. These results support the view that cognitive impairments are stable over the frst 2 years of illness, but also that the analysis of individual trajectories could help to identify a subgroup of patients with particular phenotypes, who may require specifc interventions., This work was supported by the Carlos III Health Institute (European Regional Development Funds-ERDF) of the Spanish Ministry of Economic Afairs and Competitiveness (08/1026, 11/02831, 14/01621) and the Health Department of the Government of Navarra (87/2014).
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

A neuropsychological study on Leonhard's nosological system

  • Cuesta, Manuel J.
  • Sánchez Torres, Ana María
  • Gil Berrozpe, Gustavo José
  • Lorente Omeñaca, Ruth
  • Moreno-Izco, Lucía
  • Peralta Martín, Víctor
  • SEGPEPs Group
Phenotype validation of endogenous psychosis is a problem that remains to be solved. This study investigated the neuropsychological performance of endogenous psychosis subtypes according to Wernicke–Kleist–Leonhard’s classification system (WKL). The participants included consecutive admissions of patients with schizophrenia spectrum disorder or mood disorder with psychotic symptoms (N = 98) and healthy comparison subjects (N = 50). The patients were assessed by means of semi-structured interviews and diagnosed through the WKL system into three groups: a manic-depressive illness and cycloid psychosis group (MDC), unsystematic schizophrenia (USch) and systematic schizophrenia (SSch). All the participants completed a comprehensive neuropsychological battery. The three Leonhard’s psychosis subtypes showed a common neuropsychological profile with differences in the severity of impairment relative to healthy controls. MDC patients showed better performance on premorbid intelligence, verbal memory and global cognitive index than USch and SSch patients, and they showed better performance on processing speed, and working memory than SSch patients. USch patients outperformed SSch patients in verbal memory, working memory and global cognitive index. Neuropsychological performance showed a modest accuracy for classification into the WKL nosology. Our results suggest the existence of a common profile of cognitive impairment cutting across WKL subtypes of endogenous psychosis but with significant differences on a severity continuum. In addition, classification accuracy in the three WKL subtypes by means of neuropsychological performance was modest, ranging between 40 and 64% of correctly classified patients., This work was supported by the Government of Navarra (grants 17/31, 18/41, 87/2014) and the Carlos III Health Institute (FEDER Funds) from the Spanish Ministry of Economy and Competitivity (14/01621 and 16/02148).
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Validity and utility of a set of clinical criteria for cognitive impairment associated with psychosis (CIAPs)

  • Cuesta, Manuel J.
  • Sánchez Torres, Ana María
  • Lorente Omeñaca, Ruth
  • Zandio, María
  • Moreno-Izco, Lucía
  • Peralta Martín, Víctor
Schizophrenia and other psychoses display a common profile of mild to moderate cognitive deficits that are associated with poor functional outcomes. Cognitive impairment is usually evaluated by neuropsychological assessment, and interview-based measures with good psychometric properties and high utility for clinical practice are now available. However, the extent to which a set of clinical criteria can be used as proxy measures of cognitive deficits in this population has not been tested. This study aimed to examine the empirical validity of a set of clinical criteria for cognitive impairment associated with psychosis (CIAPs). Ninety-eight patients with non-pure affective psychosis and 50 healthy-matched controls were included. The CIAPs criteria were empirically tested against antecedent, concurrent and outcome validators and by means of a neuropsychological evaluation based on MATRICS Consensus Cognitive Battery (MCCB). The CIAPs criteria showed strong associations with outcomes and certain antecedent validators and moderate associations with concurrent validators. The CIAPs criteria achieved superior neuropsychological validity compared to current DSM 5 criteria for schizophrenia, the B-criterion of DSM 5 schizophrenia or a combination of both criteria. Cognitive impairment associated with psychosis can be clinically assessed and is a useful tool for clinical practice and predicting outcomes of schizophrenia and related psychosis., This work was supported by the Government of Navarra (grants 17/31, 18/41, 87/2014) and the Carlos III Health Institute (FEDER Funds) from the Spanish Ministry of Economy and Competitivity (14/01621 and 16/02148).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A Homozygous ATP2A2 Variant Alters Sarcoendoplasmic Reticulum Ca2+-ATPase 2 Function in Skeletal Muscle and Causes a Novel Vacuolar Myopathy

  • Llansó, Laura
  • Ravenscroft, Gianina
  • Aceituno, Cristina
  • Gutiérrez, Antonio
  • Parmar, Jevin
  • Gallano, Pia
  • Caballero-Ávila, Marta
  • Carbayo, Álvaro
  • Vesperinas, Ana
  • Collet, Roger
  • Blanco, Rosa
  • Laing, Nigel
  • Hove-Madsen, Leif
  • Gallardo, Eduard
  • Olivé, Montse
Sarcoendoplasmic reticulum Ca2+-ATPase 2 (SERCA2), encoded by ATP2A2, is a key protein involved in intracellular Ca2+ homeostasis. The SERCA2a isoform is predominantly expressed in cardiomyocytes and type I myofibres. Variants in this gene are related to Darier disease, an autosomal dominant dermatologic disorder, but have never been linked to myopathy. We describe four patients suffering from a novel myopathy caused by a homozygous missense variant in ATP2A2., This work was supported by the Instituto de Salud Carlos III co-funded by ERDF/FEDER (Una manera de hacer Europa) under grant FIS PI21/01621 awarded to MO, and ‘Fundación Isabel Gemio’. LL is supported by a Grífols-funded grant (Beca de formación en enfermedades neuromusculares Isabel Illa). Whole human genome sequencing for this study was provided by the Garvan Sequencing Platform at the Garvan Institute of Medical Research. GR is supported by an Australian National Health and Medical Research Council (NHMRC) EL2 Investigator Grant (APP2007769). This work was also supported by funding from the Australian NHMRC (APP2002640), and PID2020-116927RB-C21 to LH. LL, MC, AC, AV, RC, EG, and MO are members of the European Reference Network for Neuromuscular Diseases., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Influence of social cognition as a mediator between cognitive reserve and psychosocial functioning in patients with first episode psychosis

  • González-Ortega, I.
  • González-Pinto, A.
  • Alberich, S.
  • Echeburuá, E.
  • Bernardo, M.
  • Cabrera, B.
  • Amoretti, S.
  • Lobo, A.
  • Arango, C.
  • Corripio, I.
  • Vieta, E.
  • De La Serna, E.
  • Rodriguez-Jimenez, R.
  • Segarra, R.
  • López-Ilundain, J.M.
  • Sánchez-Torres, A.M.
  • Cuesta, M.J.
  • Zorrilla, I.
  • López, P.
  • Bioque, M.
  • Mezquida, G.
  • Barcones, F.
  • De-La-Cámara, C.
  • Parellada, M.
  • Espliego, A.
  • Alonso-Solís, A.
  • Grasa, E.M.
  • Varo, C.
  • Montejo, L.
  • Castro-Fornieles, J.
  • Baeza, I.
  • Dompablo, M.
  • Torio, I.
  • Zabala, A.
  • Eguiluz, J.I.
  • Moreno-Izco, L.
  • Sanjuan, J.
  • Guirado, R.
  • Cáceres, I.
  • Garnier, P.
  • Contreras, F.
  • Bobes, J.
  • Al-Halabí, S.
  • Usall, J.
  • Butjosa, A.
  • Sarró, S.
  • Landin-Romero, R.
  • Ibáñez, A.
  • Selva, G.
Background. Social cognition has been associated with functional outcome in patients with first episode psychosis (FEP). Social cognition has also been associated with neurocognition and cognitive reserve. Although cognitive reserve, neurocognitive functioning, social cognition, and functional outcome are related, the direction of their associations is not clear. Therefore, the main aim of this study was to analyze the influence of social cognition as a mediator between cognitive reserve and cognitive domains on functioning in FEP both at baseline and at 2 years. Methods. The sample of the study was composed of 282 FEP patients followed up for 2 years. To analyze whether social cognition mediates the influence of cognitive reserve and cognitive domains on functioning, a path analysis was performed. The statistical significance of any mediation effects was evaluated by bootstrap analysis. Results. At baseline, as neither cognitive reserve nor the cognitive domains studied were related to functioning, the conditions for mediation were not satisfied. Nevertheless, at 2 years of follow-up, social cognition acted as a mediator between cognitive reserve and functioning. Likewise, social cognition was a mediator between verbal memory and functional outcome. The results of the bootstrap analysis confirmed these significant mediations (95% bootstrapped CI (-10.215 to -0.337) and (-4.731 to -0.605) respectively). Conclusions. Cognitive reserve and neurocognition are related to functioning, and social cognition mediates in this relationship.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Epicardial delivery of collagen patches with adipose-derived stem cells in rat and minipig models of chronic myocardial infarction

  • Araña, M.
  • Gavira,J . J.
  • Peña, E.
  • González, A.
  • Abizanda, G.
  • Cilla, M.
  • Pérez, M. M.
  • Albiasu, E.
  • Aguado, N.
  • Casado, M.
  • López, B.
  • González, S.
  • Soriano, M.
  • Moreno, C.
  • Merino, J.
  • García-Verdugo, J.
  • Díez, J.
  • Doblaré, M.
  • Pelacho, B.
  • Prosper, F.
Although transplantation of adipose-derived stem cells (ADSC) in chronic myocardial infarction (MI) models is associated with functional improvement, its therapeutic value is limited due to poor long-term cell engraftment and survival. Thus, the objective of this study was to examine whether transplantation of collagen patches seeded with ADSC could enhance cell engraftment and improve cardiac function in models of chronic MI. With that purpose, chronically infarcted Sprague–Dawley rats (n = 58) were divided into four groups and transplanted with media, collagen scaffold (CS), rat ADSC, or CS seeded with rat ADSC (CS-rADSC). Cell engraftment, histological changes, and cardiac function were assessed 4 months after transplantation. In addition, Göttingen minipigs (n = 18) were subjected to MI and then transplanted 2 months later with CS or CS seeded with autologous minipig ADSC (CS-pADSC). Functional and histological assessments were performed 3 months post-transplantation. Transplantation of CS-rADSC was associated with increased cell engraftment, significant improvement in cardiac function, myocardial remodeling, and revascularization. Moreover, transplantation of CS-pADSC in the pre-clinical swine model improved cardiac function and was associated with decreased fibrosis and increased vasculogenesis. In summary, transplantation of CS-ADSC resulted in enhanced cell engraftment and was associated with a significant improvement in cardiac function and myocardial remodeling
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations

  • Blanco, Gonzalo|||0000-0001-6557-3764
  • Puiggros, Anna|||0000-0001-9627-4978
  • Baliakas, Panagiotis|||0000-0002-5634-7156
  • Athanasiadou, Anastasia
  • García-Malo, MaDolores
  • Collado, Rosa|||0000-0002-8205-6192
  • Xochelli, Aliki
  • Rodríguez-Rivera, María
  • Ortega, Margarita
  • Calasanz, M.J.|||0000-0002-0374-3008
  • Luño, Elisa
  • Vargas, MªTeresa
  • Grau Cat, Javier
  • Martínez-Laperche, Carolina
  • Valiente, Alberto
  • Cervera, José|||0000-0001-8252-1106
  • Anagnostopoulos, Achilles|||0000-0003-4384-9031
  • Gimeno, Eva|||0000-0002-3534-6189
  • Abella Monreal, Eugenia|||0000-0001-9605-8458
  • Stalika, Evangelia
  • Hernández Rivas, Jesús María|||0000-0002-9661-9371
  • Ortuño, Francisco José|||0000-0003-4450-9346
  • Robles, Diego
  • Ferrer, Ana Maria|||0000-0002-3381-9472
  • Ivars, David
  • González, Marcos
  • Bosch Albareda, Francesc|||0000-0001-9241-2886
  • Abrisqueta, Pau|||0000-0001-9625-7422
  • Stamatopoulos, Kostas|||0000-0001-8529-640X
  • Espinet Solà, Blanca|||0000-0002-4294-8145
Patients with chronic lymphocytic leukemia (CLL) harboring TP53 aberrations (TP53 abs; chromosome 17p deletion and/or TP53 mutation) exhibit an unfavorable clinical outcome. Chromosome 8 abnormalities, namely losses of 8p (8p-) and gains of 8q (8q+) have been suggested to aggravate the outcome of patients with TP53 abs. However, the reported series were small, thus hindering definitive conclusions. To gain insight into this issue, we assessed a series of 101 CLL patients harboring TP53 disruption. The frequency of 8p- and 8q+ was 14.7% and 17.8% respectively. Both were associated with a significantly (P < 0.05) higher incidence of a complex karyotype (CK, ≥3 abnormalities) detected by chromosome banding analysis (CBA) compared to cases with normal 8p (N-8p) and 8q (N-8q), respectively. In univariate analysis for 10-year overall survival (OS), 8p- (P = 0.002), 8q+ (P = 0.012) and CK (P = 0.009) were associated with shorter OS. However, in multivariate analysis only CK (HR = 2.47, P = 0.027) maintained independent significance, being associated with a dismal outcome regardless of chromosome 8 abnormalities. In conclusion, our results highlight the association of chromosome 8 abnormalities with CK amongst CLL patients with TP53 abs, while also revealing that CK can further aggravate the prognosis of this aggressive subgroup.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of TP53/ATM FISH deletions

  • Puiggros, Anna|||0000-0001-9627-4978
  • Collado, Rosa|||0000-0002-8205-6192
  • Calasanz, M.J.|||0000-0002-0374-3008
  • Ortega, Margarita
  • Ruiz-Xivillé, Neus
  • Rivas Delgado, Alfredo|||0000-0003-0385-3415
  • Luño, Elisa
  • González, Teresa
  • Navarro, Blanca
  • García-Malo, MaDolores
  • Valiente, Alberto
  • Hernández, José Ángel
  • Ardanaz, María Teresa
  • Piñan, María Ángeles
  • Blanco, María Laura
  • Hernández-Sánchez, María|||0000-0001-9968-2782
  • Batlle Lopez, Ana|||0000-0003-4143-9020
  • Salgado Sánchez, Rocío Nieves|||0000-0003-1678-8982
  • Salido, Marta|||0000-0001-9988-5977
  • Ferrer, Ana Maria|||0000-0002-3381-9472
  • Abrisqueta, Pau|||0000-0001-9625-7422
  • Gimeno, Eva|||0000-0002-3534-6189
  • Abella Monreal, Eugenia|||0000-0001-9605-8458
  • Ferrá, Christelle|||0000-0003-4571-5125
  • Terol, María José
  • Ortuño, Francisco José|||0000-0003-4450-9346
  • Costa, Dolors|||0000-0002-8276-3292
  • Moreno, Carol|||0000-0003-3275-0271
  • Carbonell, Félix
  • Bosch Albareda, Francesc|||0000-0001-9241-2886
  • Delgado, Julio|||0000-0002-5157-4376
  • Espinet i Solà, Blanca
Genomic complexity identified by chromosome banding analysis (CBA) predicts a worse clinical outcome in CLL patients treated either with standard or new treatments. Herein, we analyzed the clinical impact of complex karyotypes (CK) with or without high-risk FISH deletions (ATM and/or TP53, HR-FISH) in a cohort of 1045 untreated MBL/CLL patients. In all, 99/1045 (9.5%) patients displayed a CK. Despite ATM and TP53 deletions were more common in CK (25% vs 7%; P < 0.001; 40% vs 5%; P < 0.001, respectively), only 44% (40/90) patients with TP53 deletions showed a CK. CK group showed a significant higher two-year cumulative incidence of treatment (48% vs 20%; P < 0.001), as well as a shorter overall survival (OS) (79 mo vs not reached; P < 0.001). When patients were categorized regarding CK and HR-FISH, those with both characteristics showed the worst median OS (52 mo) being clearly distinct from those non-CK and non-HR-FISH (median not reached), but no significant differences were detected between cases with only CK or HR-FISH. Both CK and TP53 deletion remained statistically significant in the multivariate analysis for OS. In conclusion, CK group is globally associated with advanced disease and poor prognostic markers. Further investigation in larger cohorts with CK lacking HR-FISH is needed to elucidate which mechanisms underlie the poor outcome of this subgroup.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Prognostic impact of DNMT3A mutation in acute myeloid leukemia with mutated NPM1

  • Oñate, Guadalupe|||0000-0003-2180-2371
  • Bataller, Alex|||0000-0002-6085-2745
  • Garrido Diaz, Ana|||0000-0002-5297-8946
  • Hoyos Colell, Montserrat|||0000-0002-1911-1734
  • Arnan, Montserrat
  • Vives Polo, Susana|||0000-0003-2217-5285
  • Coll, Rosa|||0000-0003-0560-1254
  • Tormo, Mar|||0000-0001-9622-1649
  • Sampol, Antonia|||0000-0001-7465-6203
  • Escoda, Lourdes|||0000-0003-3288-9716
  • Salamero, Olga|||0000-0003-3237-0025
  • Garcia-Guiñon, Antonio|||0000-0003-0006-4162
  • Bargay, Joan|||0000-0002-6739-3916
  • Aljarilla, Alba
  • Nomdedeu Guinot, Jose Francisco|||0000-0003-3399-346X
  • Esteve Reyner, Jordi|||0000-0002-8056-648X
  • Sierra, Jorge|||0000-0002-7966-0356
  • Pratcorona, Marta|||0000-0001-6375-596X
The negative prognostic impact of internal tandem duplication of FLT3 (FLT3- ITD) in patients with acute myeloid leukemia with mutated NPM1 (AML- NPM1) is restricted to those with a higher FLT3 -ITD allelic ratio (FLT3 high ; ≥0.5) and considered negligible in those with a wild-type (FLT3 WT)/low ITD ratio (FLT3 low). Because the comutation of DNMT3A (DNMT3A mut) has been suggested to negatively influence prognosis in AML- NPM1, we analyzed the impact of DNMT3A mut in FLT3 -ITD subsets (absent, low, and high ratios). A total of 164 patients diagnosed with AML- NPM1 included in 2 consecutive CETLAM protocols and with DNMT3A and FLT3 status available were studied. Overall, DNMT3A mut status did not have a prognostic impact, with comparable overall survival (P =.2). Prognostic stratification established by FLT3 -ITD (FLT3 WT = FLT3 low.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

European LeukemiaNet 2017 risk stratification for acute myeloid leukemia, validation in a risk-adapted protocol

  • Bataller, Alex|||0000-0002-6085-2745
  • Garrido Diaz, Ana|||0000-0002-5297-8946
  • Guijarro, Francesca|||0000-0001-6376-0929
  • Oñate, Guadalupe|||0000-0003-2180-2371
  • Díaz-Beyá, Marina|||0000-0001-9624-2597
  • Arnan, Montserrat
  • Tormo, Mar|||0000-0001-9622-1649
  • Vives Polo, Susana|||0000-0003-2217-5285
  • Queipo de Llano, María Paz
  • Coll, Rosa|||0000-0003-0560-1254
  • Gallardo, David|||0000-0003-1615-4592
  • Vall-Llovera, Ferran|||0000-0002-0718-5955
  • Escoda, Lourdes|||0000-0003-3288-9716
  • Garcia-Guiñon, Antonio|||0000-0003-0006-4162
  • Salamero, Olga|||0000-0003-3237-0025
  • Sampol, Antonia|||0000-0001-7465-6203
  • Merchan, Brayan M.|||0000-0002-6733-6006
  • Bargay, Joan|||0000-0002-6739-3916
  • Castaño-Díez, Sandra|||0000-0001-9044-4665
  • Esteban Corredera, Daniel|||0000-0001-8897-3170
  • Oliver-Caldés, Aina|||0000-0002-7921-5420
  • Rivero, Andrea|||0000-0002-4233-5031
  • Mozas, Pablo|||0000-0001-9528-4971
  • López Guerra, Mónica|||0000-0002-5545-0178
  • Pratcorona, Marta|||0000-0001-6375-596X
  • Zamora, Lurdes|||0000-0003-1713-7110
  • Costa, Dolors|||0000-0002-8276-3292
  • Rozman, Maria|||0000-0002-2641-1110
  • Nomdedeu Guinot, Jose Francisco|||0000-0003-3399-346X
  • Colomer, Dolors|||0000-0001-7486-8484
  • Brunet, Salut|||0000-0003-0491-1672
  • Sierra, Jorge|||0000-0002-7966-0356
  • Esteve Reyner, Jordi|||0000-0002-8056-648X
The 2017 European LeukemiaNet (ELN 2017) guidelines for the diagnosis and management of acute myeloid leukemia (AML) have become fundamental guidelines to assess the prognosis and postremission therapy of patients. However, they have been retrospectively validated in few studies with patients included in different treatment protocols. We analyzed 861 patients included in the Cooperativo Para el Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias-12 risk-adapted protocol, which indicates cytarabine-based consolidation for patients allocated to the ELN 2017 favorable-risk group, whereas it recommends allogeneic stem cell transplantation (alloSCT) as a postremission strategy for the ELN 2017 intermediate- and adverse-risk groups. We retrospectively classified patients according to the ELN 2017, with 327 (48%), 109 (16%), and 245 (36%) patients allocated to the favorable-, intermediate-, and adverse-risk group, respectively. The 2- and 5-year overall survival (OS) rates were 77% and 70% for favorable-risk patients, 52% and 46% for intermediate-risk patients, and 33% and 23% for adverse-risk patients, respectively. Furthermore, we identified a subgroup of patients within the adverse group (inv(3)/t(3;3), complex karyotype, and/or TP53 mutation/17p abnormality) with a particularly poor outcome, with a 2-year OS of 15%. Our study validates the ELN 2017 risk stratification in a large cohort of patients treated with an ELN-2017 risk-adapted protocol based on alloSCT after remission for nonfavorable ELN subgroups and identifies a genetic subset with a very poor outcome that warrants investigation of novel strategies.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A diphtheria toxin-based nanoparticle achieves specific cytotoxic effect on CXCR4+ lymphoma cells without toxicity in immunocompromised and immunocompetent mice

  • Falgàs, Aïda|||0000-0002-5040-2265
  • Garcia León, Annabel|||0000-0003-3007-9306
  • Núñez, Yáiza|||0000-0001-7268-2125
  • Serna, Naroa|||0000-0001-5682-8198
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Voltà-Durán, Eric|||0000-0003-0017-8274
  • Aragó, Marc|||0000-0002-9645-0131
  • Álamo, Patricia|||0000-0003-0510-5701
  • Alba Castellón, Lorena|||0000-0003-3449-7820
  • Sierra, Jorge|||0000-0002-7966-0356
  • Gallardo, Alberto|||0000-0002-2514-2027
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
  • Mangues, Ramon|||0000-0003-2661-9525
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
High rates of relapsed and refractory diffuse large B-cell lymphoma (DLBCL) patients and life-threatening side effects associated with immunochemotherapy make an urgent need to develop new therapies for DLBCL patients. Immunotoxins seem very potent anticancer therapies but their use is limited because of their high toxicity. Accordingly, the self-assembling polypeptidic nanoparticle, T22-DITOX-H6, incorporating the diphtheria toxin and targeted to CXCR4 receptor, which is overexpressed in DLBCL cells, could offer a new strategy to selectively eliminate CXCR4 DLBCL cells without adverse effects. In these terms, our work demonstrated that T22-DITOX-H6 showed high specific cytotoxicity towards CXCR4 DLBCL cells at the low nanomolar range, which was dependent on caspase-3 cleavage, PARP activation and an increase of cells in early/late apoptosis. Repeated nanoparticle administration induced antineoplastic effect, in vivo and ex vivo, in a disseminated immunocompromised mouse model generated by intravenous injection of human luminescent CXCR4 DLBCL cells. Moreover, T22-DITOX-H6 inhibited tumor growth in a subcutaneous immunocompetent mouse model bearing mouse CXCR4 lymphoma cells in the absence of alterations in the hemogram, liver or kidney injury markers or on-target or off-target organ histology. Thus, T22-DITOX-H6 demonstrates a selective cytotoxicity towards CXCR4 DLBCL cells without the induction of toxicity in non-lymphoma infiltrated organs nor hematologic toxicity.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Survival improvement of patients with FLT3 mutated acute myeloid leukemia, results from a prospective 9 years cohort

  • Oñate, Guadalupe|||0000-0003-2180-2371
  • Pratcorona, Marta|||0000-0001-6375-596X
  • Garrido Diaz, Ana|||0000-0002-5297-8946
  • Artigas-Baleri, Alícia|||0000-0003-0486-268X
  • Bataller, Alex|||0000-0002-6085-2745
  • Tormo, Mar|||0000-0001-9622-1649
  • Arnan, Montserrat
  • Vives Polo, Susana|||0000-0003-2217-5285
  • Coll, Rosa|||0000-0003-0560-1254
  • Salamero, Olga|||0000-0003-3237-0025
  • Vall-Llovera, Ferran|||0000-0002-0718-5955
  • Sampol, Antonia|||0000-0001-7465-6203
  • Garcia-Guiñon, Antonio|||0000-0003-0006-4162
  • Cervera, Marta
  • Garcia-Avila, Sara|||0000-0002-9293-2029
  • Bargay, Joan|||0000-0002-6739-3916
  • Ortín, Xavier
  • Nomdedeu Guinot, Jose Francisco|||0000-0003-3399-346X
  • Esteve Reyner, Jordi|||0000-0002-8056-648X
  • Sierra, Jorge|||0000-0002-7966-0356
Midostaurin added to intensive chemotherapy is the standard of care for acute myeloid leukemia (AML) with FLT3 mutations (FLT3 mut). We analyzed the impact of midostaurin in 227 FLT3 mut-AML patients included in the AML-12 prospective trial for fit patients ≤70 years (#NCT04687098). Patients were divided into an early (2012-2015) and late (2016-2020) cohorts. They were uniformly treated except for the addition of midostaurin in 71% of late group patients. No differences were observed in response rates or the number of allotransplants between groups. Outcome was improved in the late period: 2-year relapse incidence decreased from 42% vs 29% in early vs late group (p = 0.024) and 2-year overall survival (OS) improved from 47% vs 61% (p = 0.042), respectively. The effect of midostaurin was evident in NPM1 mut patients (n = 151), with 2-yr OS of 72% (exposed) vs 50% (naive) patients (p = 0.011) and mitigated FLT3 -ITD allelic ratio prognostic value: 2-yr OS with midostaurin was 85% and 58% in low and high ratio patients (p = 0.049) vs 67% and 39% in naive patients (p = 0.005). In the wild-type NPM1 subset (n = 75), we did not observe significant differences between both study periods. In conclusion, this study highlights the improved outcome of FLT3 mut AML fit patients with the incorporation of midostaurin.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo

  • Núñez, Yáiza|||0000-0001-7268-2125
  • Garcia León, Annabel|||0000-0003-3007-9306
  • Falgàs, Aïda|||0000-0002-5040-2265
  • Serna, Naroa|||0000-0001-5682-8198
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Garrido Diaz, Ana|||0000-0002-5297-8946
  • Sierra, Jorge|||0000-0002-7966-0356
  • Gallardo, Alberto|||0000-0002-2514-2027
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Mangues, Ramon|||0000-0003-2661-9525
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
Despite advances in the development of targeted therapies for acute myeloid leukemia (AML), most patients relapse. For that reason, it is still necessary to develop novel therapies that improve treatment effectiveness and overcome drug resistance. We developed T22-PE24-H6, a protein nanoparticle that contains the exotoxin A from the bacterium Pseudomonas aeruginosa and is able to specifically deliver this cytotoxic domain to CXCR4 + leukemic cells. Next, we evaluated the selective delivery and antitumor activity of T22-PE24-H6 in CXCR4 + AML cell lines and BM samples from AML patients. Moreover, we assessed the in vivo antitumor effect of this nanotoxin in a disseminated mouse model generated from CXCR4 + AML cells. T22-PE24-H6 showed a potent, CXCR4-dependent antineoplastic effect in vitro in the MONO-MAC-6 AML cell line. In addition, mice treated with nanotoxins in daily doses reduced the dissemination of CXCR4 + AML cells compared to buffer-treated mice, as shown by the significant decrease in BLI signaling. Furthermore, we did not observe any sign of toxicity or changes in mouse body weight, biochemical parameters, or histopathology in normal tissues. Finally, T22-PE24-H6 exhibited a significant inhibition of cell viability in CXCR4 high AML patient samples but showed no activity in CXCR4 low samples. These data strongly support the use of T22-PE24-H6 therapy to benefit high-CXCR4-expressing AML patients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Influence of social cognition as a mediator between cognitive reserve and psychosocial functioning in patients with first episode psychosis

  • González-Ortega, Itxaso|||0000-0001-7074-4353
  • González-Pinto, Ana|||0000-0002-2568-5179
  • Alberich, Susana|||0000-0002-4945-3428
  • Echeburuá, Enrique|||0000-0001-7654-0781
  • Bernardo, Miquel|||0000-0001-8748-6717
  • Cabrera, Bibiana|||0000-0002-7749-5449
  • Amoretti, Silvia|||0000-0001-6017-2734
  • Lobo, Antonio|||0000-0002-9098-655X
  • Arango, Celso|||0000-0003-3382-4754
  • Corripio, Iluminada|||0000-0003-2562-711X
  • Vieta, Eduard|||0000-0002-0548-0053
  • de la Serna, Elena|||0000-0002-7869-9881
  • Rodriguez-Jimenez, Roberto|||0000-0003-2251-7249
  • Segarra, Rafael|||0000-0002-2033-8151
  • López-Ilundain, Jose Manuel|||0000-0003-0361-0667
  • Sánchez Torres, Ana Maria|||0000-0002-9505-2406
  • Cuesta, Manuel J.|||0000-0003-0250-5718
  • Zorrilla, Iñaki|||0000-0001-6444-8208
  • López, Platas
  • Bioque, Miquel|||0000-0001-6887-7149
  • Mezquida, Gisela|||0000-0002-6080-2203
  • Barcones, Fe
  • Cámara, Concepción de la|||0000-0003-2284-7862
  • Parellada, Mara|||0000-0001-7977-3601
  • Espliego, Ana
  • Alonso-Solís, Anna|||0000-0002-5393-9391
  • Grasa, Eva|||0000-0003-1100-7489
  • Varo, Cristina|||0000-0002-8859-3052
  • Montejo, Laura|||0000-0003-4407-9454
  • Castro-Fornieles, Josefina|||0000-0003-0632-2687
  • Baeza, Illyana
  • Dompablo, Mónica|||0000-0002-7195-3816
  • Torio, Iosune|||0000-0002-1771-1891
  • Zabala Rabadán, Arantzazu
  • Eguiluz, J.I.
  • Moreno-Izco, Lucía
  • Sanjuan, Julio
  • Guirado, Ramon|||0000-0003-0259-5709
  • Cáceres, Iris
  • Garnier, P.
  • Contreras, Fernando|||0000-0003-2929-2804
  • Bobes, Julio|||0000-0003-2187-4033
  • Al-Halabí, Susana|||0000-0003-1162-2115
  • Usall, Judith|||0000-0002-1746-7737
  • Butjosa Molines, Anna|||0000-0001-5317-9508
  • Sarró, Salvador|||0000-0003-1835-2189
  • Landin-Romero, Ramon|||0000-0003-0485-8090
  • Ibañez, Angela|||0000-0003-2751-0150
  • Selva, Gabriel
Social cognition has been associated with functional outcome in patients with first episode psychosis (FEP). Social cognition has also been associated with neurocognition and cognitive reserve. Although cognitive reserve, neurocognitive functioning, social cognition, and functional outcome are related, the direction of their associations is not clear. Therefore, the main aim of this study was to analyze the influence of social cognition as a mediator between cognitive reserve and cognitive domains on functioning in FEP both at baseline and at 2 years. The sample of the study was composed of 282 FEP patients followed up for 2 years. To analyze whether social cognition mediates the influence of cognitive reserve and cognitive domains on functioning, a path analysis was performed. The statistical significance of any mediation effects was evaluated by bootstrap analysis. At baseline, as neither cognitive reserve nor the cognitive domains studied were related to functioning, the conditions for mediation were not satisfied. Nevertheless, at 2 years of follow-up, social cognition acted as a mediator between cognitive reserve and functioning. Likewise, social cognition was a mediator between verbal memory and functional outcome. The results of the bootstrap analysis confirmed these significant mediations (95% bootstrapped CI (-10.215 to-0.337) and (-4.731 to-0.605) respectively). Cognitive reserve and neurocognition are related to functioning, and social cognition mediates in this relationship.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Mutation update for the ACTN2 gene

  • Ranta-aho, Johanna
  • Olivé i Plana, Montserrat|||0000-0001-5727-0165
  • Vandroux, Marie
  • Roticiani, Giorgia
  • Domínguez-González, Cristina|||0000-0001-5151-988X
  • Johari, Mridul|||0000-0002-3549-558X
  • Torella, Annalaura
  • Böhm, Johann|||0000-0001-8019-9504
  • Turon-Sans, Janina|||0000-0002-8842-4646
  • Nigro, Vincenzo
  • Hackman, Peter
  • Laporte, Jocelyn
  • Udd, Bjarne
  • Savarese, Marco|||0000-0002-2591-244X
ACTN2 encodes alpha-actinin-2, a protein expressed in human cardiac and skeletal muscle. The protein, located in the sarcomere Z-disk, functions as a link between the anti-parallel actin filaments. This important structural protein also binds N-terminal titins, and thus contributes to sarcomere stability. Previously, ACTN2 mutations have been solely associated with cardiomyopathy, without skeletal muscle disease. Recently, however, ACTN2 mutations have been associated with novel congenital and distal myopathy. Previously reported variants are in varying locations across the gene, but the potential clustering effect of pathogenic locations is not clearly understood. Further, the genotype-phenotype correlations of these variants remain unclear. Here we review the previously reported ACTN2-related molecular and clinical findings and present an additional variant, c.1840-2A.